Literature DB >> 27013311

Controversy in public hospital reforms in China.

Xiao Guan1, Lin Qi1, Longfei Liu2.   

Abstract

Mesh：

Year:  2016        PMID： 27013311     DOI： 10.1016/S2214-109X(16)00041-3

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  7 in total

1.  Qualitative analysis of direction of public hospital reforms in China.

Authors:  Dahai Zhao; Zhiruo Zhang
Journal:  Front Med       Date:  2017-07-03       Impact factor: 4.592

2.  Impact of organizational and individual factors on patient-provider relationships: A national survey of doctors, nurses and patients in China.

Authors:  Ping Zhang; Fang Wang; Yao Cheng; Liu Yi Zhang; Bei Zhu Ye; Hong Wei Jiang; Yi Sun; Xi Zhu; Yuan Liang
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

3.  Outpatient Surgery in Zhongshan Ophthalmic Center: Promise and Problems.

Authors:  Zhi-Gang Fan; Dan-Dan Zhang; Zhong-Wen Li; Yao Yang; Xiao-Feng Lin
Journal:  Chin Med J (Engl)       Date:  2017-07-05       Impact factor: 2.628

4.  Assessing Productivity Development of Public Hospitals: A Case Study of Shanghai, China.

Authors:  Juan Du; Shuhong Cui; Hong Gao
Journal:  Int J Environ Res Public Health       Date:  2020-09-16       Impact factor: 3.390

5.  Satisfaction with Public Hospital Reform and Associated Factors Among Medical Staff: A Cross-Sectional Survey in Wuhan, China.

Authors:  Siyu Tao; Zhiming Jiao; Jinzhu Xie; Qianyu Wang
Journal:  Risk Manag Healthc Policy       Date:  2021-12-20

6.  Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.

Authors:  Yulei Zhu; Ying Wang; Xiaoluan Sun; Xin Li
Journal:  Int J Environ Res Public Health       Date:  2019-10-03       Impact factor: 3.390

7.  Achieving SDG related sexual and reproductive health targets in China: what are appropriate indicators and how we interpret them?

Authors:  Jing Fang; Shenglan Tang; Xiaoping Tan; Rachel Tolhurst
Journal:  Reprod Health       Date:  2020-06-01       Impact factor: 3.223
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.